CTNNB1 and neoplasm: Melanoma cells with active VDR signaling and a suppressed Wnt-beta catenin pathway show increased tumor antigen release, antigen presentation, CD4+ T cell activation and priming, and increased CTL and NK infiltration and tumor cell killing [145].